Human Trial Of Covishield Vaccine Begins At Mumbai’s KEM Hospital
Mumbai : Human trials of the corona vaccine Covishield have begun at the King Edward Memorial Hospital (KEMH) in Mumbai. Dean of the hospital Hemant Deshmukh said that on Saturday, a human test of the vaccine will be done on three people. The process of human testing of the vaccine has started. He said that we have screened 13 people so far. The screening of 10 of these people was completed on Friday.
Pune-based Serum Institute has tied up with British Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by Oxford University. The first shot of the vaccine will be developed on Saturday.
He said that another person would get a placebo as part of the standard testing process. KEM is the first hospital in Mumbai to undergo a human test of the vaccine being manufactured by the Serum Institute of India. Covishield vaccine has been developed by Oxford University and Serum Institute of Pune is preparing it in India.
At the same time, the process for the final phase of this vaccine trial has started in PGI Chandigarh. 17 institutes have been selected for the trial of this vaccine in the country. PGI, Chandigarh is also involved in this.
After getting the approval from the Data Safety and Monitoring Board New Delhi, the process of the third or final phase of human trials at PGI Chandigarh has started from Wednesday. On Wednesday, 10 volunteers were selected in the PGI for the trial. All the necessary tests were done and found fit for trial.